Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 131,121
  • Shares Outstanding, K 69,011
  • Annual Sales, $ 350 K
  • Annual Income, $ -50,390 K
  • EBIT $ -59 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.19
  • Price/Sales 361.67
  • Price/Cash Flow N/A
  • Price/Book 1.53
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.90
  • Most Recent Earnings $-0.23 on 05/02/24
  • Next Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.19
  • Low Estimate -0.25
  • Prior Year -0.22
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5901 +19.49%
on 05/06/24
2.0900 -9.09%
on 05/21/24
+0.2900 (+18.01%)
since 05/03/24
3-Month
1.5400 +23.38%
on 05/02/24
2.1500 -11.63%
on 03/20/24
+0.1100 (+6.15%)
since 03/04/24
52-Week
1.0801 +75.91%
on 11/13/23
2.4500 -22.45%
on 06/16/23
-0.4200 (-18.10%)
since 06/02/23

Most Recent Stories

More News
Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q2 Earnings Snapshot

Atyr Pharma: Q2 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9000 (+2.70%)
aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis

Company is investigating efzofitimod in global pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis patients...

LIFE : 1.9000 (+2.70%)
Love Hemp Group PLC Announces Directorate Changes and Trading Suspension Update

LONDON, UK / ACCESSWIRE / July 8, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) the brand-led consumer goods company focussed on CBD health and wellness solutions, gives an update regarding its Board...

WRHLF : 0.0001 (unch)
LIFE : 1.9000 (+2.70%)
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. ...

LIFE : 1.9000 (+2.70%)

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 2.0900
2nd Resistance Point 2.0200
1st Resistance Point 1.9600
Last Price 1.9000
1st Support Level 1.8300
2nd Support Level 1.7600
3rd Support Level 1.7000

See More

52-Week High 2.4500
Fibonacci 61.8% 1.9267
Last Price 1.9000
Fibonacci 50% 1.7651
Fibonacci 38.2% 1.6034
52-Week Low 1.0801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar